The relationship between microRNAs and Rab family GTPases in human cancers.
Rabs
cancer therapy
miRNAs
Journal
Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222
Informations de publication
Date de publication:
08 2019
08 2019
Historique:
received:
06
06
2018
accepted:
30
11
2018
pubmed:
5
1
2019
medline:
22
5
2020
entrez:
5
1
2019
Statut:
ppublish
Résumé
microRNAs (miRNAs), as a group of noncoding RNAs, posttranscriptionally control gene expression by binding to 3'-untranslated region (3'-UTR). Ras-associated binding (Rab) proteins function as molecular switches for regulating vesicular transport, which mainly have oncogenic roles in cancer development and preventing the efficacy of chemotherapies. Increased evidence supported that miRNAs/Rabs interaction have been determined as potential therapeutics for cancer therapy. Nevertheless, instability and cross-targeting of miRNAs are main limitations of using miRNA-based therapeutic. The mutual interplay between Rabs and miRNAs has been poorly understood. In the present review, we focused on the essence and activity of these molecules in cancer pathogenesis. Also, numerous hindrances and potential methods in the expansion of miRNA as an anticancer therapeutics are mentioned.
Substances chimiques
3' Untranslated Regions
0
MicroRNAs
0
Vesicular Transport Proteins
0
rab GTP-Binding Proteins
EC 3.6.5.2
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
12341-12352Informations de copyright
© 2019 Wiley Periodicals, Inc.